Profile
SPRC VRTX REGN VRNA ARGX ALNY
Company Name SciSparc Ltd. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $356.06K $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.00K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Oz Adler Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
SPRC VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
SPRC VRTX REGN VRNA ARGX ALNY
Last Close $2.47 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $8.19 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.21 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -69.84 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 1076.19 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
SPRC VRTX REGN VRNA ARGX ALNY
1 Month Return -35.34 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -45.59 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 681.89 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 407.08 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 586.11 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 933.47 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SPRC VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -4768 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
SPRC VRTX REGN VRNA ARGX ALNY
Asset Growth -7.47 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth -76.96 % 1.16 % - 26.81 %
Revenue Growth -54.64 % 0.99 % - 22.97 %
Revenue 3 Year -83.5 % 20.64 % -15.89 % 147.1 %
Revenue 5 Year - 73.64 % - 775.72 %
Revenue 10 Year - 285.02 % - 2487.4 %
EBIT Growth -27.41 % 9.09 % -131.37 % 24.59 %
Net Income Growth -22.69 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share 85.37 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share - 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share - 680.22 % -35.51 % 55.09 %
Operating Income Growth -26.73 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) 13.3 % - -143.33 % -107.98 %
Operating 3 Year CFG 86.38 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG - -100 % 54.81 % 97.44 %
Operating 10 Year CFG - -100 % 40.15 % 97.08 %
EPS Growth 91.39 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth 98.5 % 8.19 % -208.93 % 38.07 %
Book Value Per Share -71.59 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share -86.47 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share - 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share - 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth -39.47 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth 13.3 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
SPRC VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 21.9 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -236.82 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -330.17 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -19796.04 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 92.03 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 66.14 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -2156.85 % 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -194.45 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM 0.9 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 0.9 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM 4.7 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM 2260.98 % 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 18.04 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -9.16 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -9.16 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 300.84 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -514.35 % 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 99.98 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -194.45 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -0.07 36.72 20 -995.27 127.92 195.85
Price To Operating Cash Flows Ratio TTM -0.07 32.86 16.23 -126.33 144.41 162.25
Price Cash Flow Ratio TTM -0.07 32.86 16.23 -126.33 144.41 162.25
Income Statement (TTM)
SPRC VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $0B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 38.74% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.01B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.01B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -1.08 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
SPRC VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $0.01B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $15.75B $0.02B $1.93B $1.73B
Total Debt $0B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0.01B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
SPRC VRTX REGN VRNA ARGX ALNY
Net Income $-0.01B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.555
AARD Aardvark Therapeutics, Inc. Common Stock 12.545
ABCL AbCellera Biologics Inc. 3.115
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.015
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.505
ABPWW 0.0132
ABSI Absci Corporation 2.5999
ABUS Arbutus Biopharma Corporation 4.1302
ABVC ABVC BioPharma, Inc. 1.65
ABVX Abivax SA American Depositary Shares 117.75
ACAD ACADIA Pharmaceuticals Inc. 22.3406
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.75
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.3
ACIU AC Immune SA 2.99
ETFs With Exposure to SPRC
Ticker ETF Name Weight Percentage Price
AVEM Avantis Emerging Markets Equity ETF 0 86.87
AVES Avantis Emerging Markets Value ETF 0.02 65.0496
AVEE American Century Etf Trust - Avantis Emerging Markets Small Cap Equiy Etf 0.05 67.9784
AVXC Avantis Emerging Markets ex-China Equity ETF 0.02 72.95
Unlock